Brenner Benjamin, Grabowski Eric F, Hellgren Margaretta, Kenet Gili, Massicotte Patricia, Manco-Johnson Marilyn, Mathew Prasad, Muntean Wolfgang, Schlegel Nicole, Nowak-Göttl Ulrike
Thrombosis and Hemostasis Unit, Department of Hematology, Rambam Medical Center, PO Box 9602, Hiafa 31096, Israel.
Thromb Haemost. 2004 Oct;92(4):678-81. doi: 10.1160/TH04-02-0096.
The implications of currently available data on the association of gestational vascular complications with thrombophilia are presented in this consensus report. Screening is recommended for women with the following previous complications: fetal loss including three or more first trimester loss, two or more second trimester loss, or any stillbirth; early, severe or recurrent preeclampsia and severe intrauterine growth restriction. Maternal antithrombotic therapy is currently evaluated in women with thrombophilia and previous complications.
本共识报告介绍了目前可得的关于妊娠期血管并发症与易栓症关联的数据的意义。建议对有以下既往并发症的女性进行筛查：胎儿丢失，包括三次或更多次孕早期丢失、两次或更多次孕中期丢失或任何死产；早发型、重度或复发性子痫前期以及重度胎儿生长受限。目前正在对有易栓症和既往并发症的女性进行母体抗栓治疗的评估。
